Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of hodgkin and reed-sternberg cells

Modern Pathology

Volumn 13, Issue 12, 2000, Pages 1324-1331

  Izban, K F ^a   Ergin, M ^a   Martinez, R L ^a   Alkan, S ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hodgkin's disease; Immunohistochemistry; TNF; TRAF proteins

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL LINE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; REED STERNBERG CELL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; PROTEINS; REED-STERNBERG CELLS; RNA, VIRAL; TNF RECEPTOR-ASSOCIATED FACTOR 1; TNF RECEPTOR-ASSOCIATED FACTOR 2; TUMOR CELLS, CULTURED;

EID: 0034543631     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880243     Document Type: Article

References (42)

1. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling
2. Tumor necrosis factor receptor and Fas signaling mechanisms
3. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity
4. Induction of nuclear factor-κB by the CD30 receptor is mediated by TRAF1 and TRAF2
5. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40
6. Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation
7. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor
8. Role of the TRAF binding site and NF-κB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression
9. Association of TRAF1, TRAF2 and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: Role in NF-κB activation
10. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
11. Association of a RING finger protein with the cytoplasmic domain of the human type-2 tumour necrosis factor receptor
12. A novel member of the TRAF family of putative signal transducing proteins binds to the cytoplasmic domain of CD40
13. A novel RING finger protein interacts with the cytoplasmic domain of CD40
14. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFκB activation
15. TRAF1 is a TNF inducible regulator of NF-κB activation
16. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
17. Localization of the major NF-κB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs
18. Identification of TRAF6, a novel tumor necrosis factor receptor-associated protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
19. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
20. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain
21. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
22. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
23. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death
24. RAIDD is a new "death" adapter molecule
25. The nature of Reed-Sternberg cells: Phenotype, genotype, and other properties
26. Expression of cytokine genes, cytokine receptor genes, and transcription factors in cultured Hodgkin and Reed Sternberg cells
27. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
28. Hodgkin's disease: A cytokine producing tumor - A review
29. CD40 expression in Hodgkin's disease
30. Frequent expression of FAS/APO-1 in Hodgkin's disease and anaplastic large cell lymphoma
31. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas
32. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells
33. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease
34. Constitutive nuclear factor NF-κB-Rel A activation is required for proliferation and survival of Hodgkin's disease tumor cells
35. Inhibition of NF-κB induced apoptosis in Hodgkin's disease cell lines is independent of the cell death protease CPP32/Caspase 3
36. Activation of NF-κB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-κB inducing kinase. Identification of a novel TRAF6 interaction motif
37. Gene expression by single Reed-Sternberg cells: Pathways to apoptosis and activation
38. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin's disease and Epstein-Barr virus-transformed lymphoid cells
39. Hodgkin's disease: A tumor with disturbed immunological pathways
40. Structural and biological features of the TNF receptor and TNF ligand signals in the pathobiology of Hodgkin's disease
41. Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis
42. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma